IOVS Journal of Applied Physiology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

(Investigative Ophthalmology and Visual Science. 2003;44:505-509.)
© 2003 by The Association for Research in Vision and Ophthalmology, Inc.
DOI:  10.1167/iovs.02-0499
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Talwar, D.
Right arrow Articles by Biswas, N. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Talwar, D.
Right arrow Articles by Biswas, N. R.

Intraocular Ciprofloxacin Levels after Oral Administration in Silicone Oil-Filled Eyes

Dinesh Talwar,1 Amol Kulkarni,1 RajVardhan Azad,1 Suresh K. Gupta,2 T. Velpandian,2 YogRaj Sharma,1 Rajpal,1 and Nihar R. Biswas3

1From the Dr. Rajendra Prasad Centre for Ophthalmic Sciences, the 2Department of Pharmacology, and the 3Department of Ocular Pharmacology, All India Institute of Medical Sciences, New Delhi, India.

PURPOSE. To evaluate penetration of oral ciprofloxacin in the retro-silicone oil space fluid (RSOF) in silicone oil (SO)-filled eyes.

METHODS. One dose of 750 mg ciprofloxacin was given to two groups of five patients with vitrectomized eyes with SO endotamponade, 4 hours (group I) and 8 hours (group II) before SO removal. In 10 vitrectomized eyes with SO endotamponade (group III) and another 10 patients scheduled for vitrectomy for the first time (group IV), two 750-mg doses every 12 hours, with the last dose 12 hours before surgery, were given. Blood samples were taken at the time of collection of RSOF samples in groups I, II, and III and of the vitreous in group IV. All samples were assayed for ciprofloxacin by high-performance liquid chromatography.

RESULTS. The mean drug concentration in the RSOF was 0.34 ± 0.09, 0.37 ± 0.04, 0.84 ± 0.29, and 0.44 ± 0.11 µg/mL in groups I, II, III, and IV respectively. The mean serum concentration was 1.29 ± 0.63, 1.08 ± 0.14, 1.93 ± 0.84, and 1.34 ± 0.55 µg/mL in groups I, II, III, and IV respectively with no statistically significant difference between groups III and IV (P = 0.081).

CONCLUSIONS. Antibiotic levels in the RSOF in SO-filled eyes after oral administration of ciprofloxacin in two 750-mg doses exceeded the minimal inhibitory concentration for 90% of isolates (MIC90) for most bacterial species and was higher than levels reached in the vitreous in nonvitrectomized eyes (P = 0.001).






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2003 by the Association for Research in Vision and Ophthalmology